REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biohimmak Diagnostika AO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biohimmak Diagnostika AO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Biohimmak Diagnostika AO is an enterprise in Russia, with the main office in Moscow. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on January 14, 2003. It currently has a total number of 50 (2022) employees. The latest financial highlights indicate a net sales revenue increase of 50.2% in 2023. Its’ total assets recorded a growth of 25.88%. The enterprise’s net profit margin increased by 4.17% in 2023.

Headquarters
Lomonosovskii, 25, 2, 60/3
Moscow; Moscow; Postal Code: 119311

Contact Details: Purchase the Biohimmak Diagnostika AO report to view the information.

Website: http://www.biochemmack.ru

Basic Information
Total Employees:
Purchase the Biohimmak Diagnostika AO report to view the information.
Outstanding Shares:
Purchase the Biohimmak Diagnostika AO report to view the information.
Registered Capital:
Purchase the Biohimmak Diagnostika AO report to view the information.
Incorporation Date:
January 14, 2003
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
17%
Purchase this report to view the information.
17%
Purchase this report to view the information.
17%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Biohimmak Diagnostika AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
50.2%▲
Total operating revenue
50.2%▲
Operating profit (EBIT)
94.32%▲
Net Profit (Loss) for the Period
126.69%▲
Total assets
25.88%▲
Total equity
28.45%▲
Operating Profit Margin (ROS)
3.68%▲
Net Profit Margin
4.17%▲
Return on Equity (ROE)
12.31%▲
Quick Ratio
0.28%▲
Cash Ratio
-0.8%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo